Who
Joseph L. Schocken
Director
Company insider
Files Form 4 as: Director, Omeros; Director and Other, Broadmark Realty Capital.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 3 Feb 2020
- Last trade
- 12 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Aug 2026filed 18 Aug 2026 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 12 Aug 2026filed 18 Aug 2026 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 18 Feb 2021filed 10 Feb 2022 | Broadmark Realty Capital | SEC FORM 4 Code G | —37,882 at $0.00 | filing |
| 18 Feb 2021filed 10 Feb 2022 | Broadmark Realty Capital | SEC FORM 4 Code G | —251,571 at $0.00 | filing |
| 8 Jan 2021filed 10 Feb 2022 | Broadmark Realty Capital | SEC FORM 4 Code G | —50,000 at $0.00 | filing |
| 3 Feb 2020filed 5 Feb 2020 | Broadmark Realty Capital | SEC FORM 4 Code A | —95,694 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.